- Home
- BMY vs MDLZ Comparison
BMY vs MDLZ Comparison
Compare BMY & MDLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- MDLZ
- Stock Information
- Founded
- BMY 1887
- MDLZ 2000
- Country
- BMY United States
- MDLZ United States
- Employees
- BMY N/A
- MDLZ N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- MDLZ Packaged Foods
- Sector
- BMY Health Care
- MDLZ Consumer Staples
- Exchange
- BMY Nasdaq
- MDLZ Nasdaq
- Market Cap
- BMY 94.0B
- MDLZ 78.9B
- IPO Year
- BMY N/A
- MDLZ N/A
- Fundamental
- Price
- BMY $43.68
- MDLZ $58.40
- Analyst Decision
- BMY Hold
- MDLZ Buy
- Analyst Count
- BMY 14
- MDLZ 18
- Target Price
- BMY $57.54
- MDLZ $69.72
- AVG Volume (30 Days)
- BMY 15.5M
- MDLZ 7.6M
- Earning Date
- BMY 10-30-2025
- MDLZ 10-28-2025
- Dividend Yield
- BMY 5.82%
- MDLZ 3.32%
- EPS Growth
- BMY N/A
- MDLZ N/A
- EPS
- BMY 2.49
- MDLZ 2.69
- Revenue
- BMY $47,704,000,000.00
- MDLZ $37,645,000,000.00
- Revenue This Year
- BMY N/A
- MDLZ $7.67
- Revenue Next Year
- BMY N/A
- MDLZ $4.38
- P/E Ratio
- BMY $17.14
- MDLZ $21.49
- Revenue Growth
- BMY 2.57
- MDLZ 4.13
- 52 Week Low
- BMY $42.52
- MDLZ $53.95
- 52 Week High
- BMY $63.33
- MDLZ $71.15
- Technical
- Relative Strength Index (RSI)
- BMY 45.50
- MDLZ 35.99
- Support Level
- BMY $42.52
- MDLZ $56.99
- Resistance Level
- BMY $45.23
- MDLZ $62.43
- Average True Range (ATR)
- BMY 0.68
- MDLZ 1.27
- MACD
- BMY -0.00
- MDLZ -0.35
- Stochastic Oscillator
- BMY 42.88
- MDLZ 22.62
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About MDLZ Mondelez International Inc.
Mondelez has operated independently since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack enclave with a presence in the biscuit (49% of sales as of the end of fiscal 2024), chocolate (31%), gum/candy (11%), beverage (3%), and cheese and grocery (6%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, and Cadbury. The firm derives around one-third of its revenue from developing markets, just more than one-third from Europe, and the remainder from North America.